With Sobia Akram, Corporate Vice President, Global Business Ethics Compliance Office & Programme at Novo Nordisk.

The Dawn of a Digital Industry

In this Dawn Talks, our CEO and founder, Daniel Daugaard, sits down with Sobia Akram, Corporate Vice President, Global Business Ethics Compliance Office &amp; Programme at Novo Nordisk. They discuss the early beginnings of Dawn Health and the impact of COVID-19 on the industry, the role of SaMD in clinical trials, RWE, outcome-based reimbursement, data privacy, business ethics, and having a quality mindset.

COVID-19SaMD in Clinical TrialsRWEReimbursementData PrivacyBusiness ethics